Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $199,325 - $233,031
-3,636 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$46.4 - $67.43 $77,209 - $112,203
-1,664 Reduced 31.4%
3,636 $203,000
Q4 2019

Jan 27, 2020

SELL
$49.21 - $64.19 $515,720 - $672,711
-10,480 Reduced 66.41%
5,300 $340,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $769,432 - $997,769
15,780 New
15,780 $879,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alterna Wealth Management, Inc Portfolio

Follow Alterna Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alterna Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alterna Wealth Management, Inc with notifications on news.